Bio-Rad Laboratories (BIO) Receivables - Other (2019 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Receivables - Other for 7 consecutive years, with $11.9 million as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 9.16% to $11.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, down 9.16% year-over-year, with the annual reading at $11.9 million for FY2025, 9.16% down from the prior year.
- Receivables - Other for Q4 2025 was $11.9 million at Bio-Rad Laboratories, up from $9.5 million in the prior quarter.
- The five-year high for Receivables - Other was $14.8 million in Q1 2023, with the low at $1.4 million in Q1 2021.
- Average Receivables - Other over 5 years is $9.0 million, with a median of $9.6 million recorded in 2024.
- The sharpest move saw Receivables - Other decreased 26.32% in 2021, then soared 427.27% in 2022.
- Over 5 years, Receivables - Other stood at $2.2 million in 2021, then skyrocketed by 427.27% to $11.6 million in 2022, then increased by 2.59% to $11.9 million in 2023, then increased by 10.08% to $13.1 million in 2024, then fell by 9.16% to $11.9 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $11.9 million, $9.5 million, and $8.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.